The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DENTSPLY SIRONA is on a conditional recovery watch, rated Hold with a bullish bias, pending clear evidence of turnaround.

DENTSPLY SIRONA Inc. announced the appointment of Matthew E. Garth as Executive Vice President and Chief Financial Officer, effective May 30, 2025. Garth brings nearly 30 years of financial management ...

Stocks That Just Didn’t Work Out. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is one of the stocks discussed by Jim Cramer. DENTSPLY ...

Dentsply Sirona Inc. (NASDAQ:XRAY) stock surged about 15% Thursday, and was on track for the biggest single-day advance since 2019 after posting earnings that topped estimates. The company reported ...

(Reuters) - Dentsply International Inc said on Tuesday it would buy peer Sirona Dental Systems Inc in a $5.56 billion all-stock deal, creating the world's largest dental equipment maker. Sirona ...

PDS Health ® and Dentsply Sirona today announced that PDS Health practices have surpassed five million CEREC chairside restorations, a milestone that underscores the scale, consistency and long-term ...

Throughout the last three months, 5 analysts have evaluated Dentsply Sirona (NASDAQ:XRAY), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ...

We peg Dentsply Sirona’s XRAY fair value estimate at $28 per share. Our model is underpinned by a 5-year sales CAGR of 3.5% with moderate year-over-year margin expansion and a no-moat rating. Dentsply ...

Detailed price information for Dentsply Sirona Inc (XRAY-Q) from The Globe and Mail including charting and trades.

CHARLOTTE, N.C., May 26, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the ...

The latest price target for Dentsply Sirona (NASDAQ:XRAY) was reported by Barrington Research on July 22, 2025. The analyst firm set a price target for $21.00 expecting XRAY to rise to within 12 ...